| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 3,569,000 | 4,315,000 | 4,902,000 | 5,076,000 | | Cost of Revenue | 3,045,000 | 3,842,000 | 4,217,000 | 4,324,000 | | | Gross Profit | 524,000 | 473,000 | 685,000 | 752,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 327,000 | 379,000 | 477,000 | 502,000 | | Non Recurring | 24,000 | 77,000 | 24,000 | 40,000 | | Others | 7,000 | 7,000 | 7,000 | 7,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 166,000 | 10,000 | 177,000 | 203,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 150,000 | (150,000) | 7,000 | | Earnings Before Interest And Taxes | 166,000 | 160,000 | 27,000 | 210,000 | | Interest Expense | 109,000 | 269,000 | (95,000) | 80,000 | | Income Before Tax | 57,000 | (109,000) | 122,000 | 130,000 | | Income Tax Expense | (16,000) | (160,000) | (46,000) | 2,000 | | Minority Interest |
-
| (7,000) | (5,000) | (11,000) | | | | Net Income From Continuing Ops | 73,000 | 44,000 | 163,000 | 117,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 73,000 | 44,000 | 163,000 | 117,000 | | Preferred Stock And Other Adjustments | (5,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $68,000 | $44,000 | $163,000 | $117,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
